These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 26846153

  • 1. Norcantharidin Suppresses Colon Cancer Cell Epithelial-Mesenchymal Transition by Inhibiting the αvβ6-ERK-Ets1 Signaling Pathway.
    Peng C, Li Z, Niu Z, Niu W, Xu Z, Gao H, Niu W, Wang J, He Z, Gao C, Lin P, Agrez M, Zhang Z, Niu J.
    Sci Rep; 2016 Feb 05; 6():20500. PubMed ID: 26846153
    [Abstract] [Full Text] [Related]

  • 2. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells.
    Qiu P, Wang S, Liu M, Ma H, Zeng X, Zhang M, Xu L, Cui Y, Xu H, Tang Y, He Y, Zhang L.
    BMC Cancer; 2017 Jan 13; 17(1):55. PubMed ID: 28086832
    [Abstract] [Full Text] [Related]

  • 3. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F, Wang S, Wei Y, Wu J, Huang G, Chen J, Shi J, Xia J.
    Biomed Pharmacother; 2018 Jul 13; 103():1092-1100. PubMed ID: 29710674
    [Abstract] [Full Text] [Related]

  • 4. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug 13; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 5. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP, Jing W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ.
    BMC Cancer; 2015 Jul 19; 15():527. PubMed ID: 26187792
    [Abstract] [Full Text] [Related]

  • 6. Norcantharidin induces HT-29 colon cancer cell apoptosis through the alphavbeta6-extracellular signal-related kinase signaling pathway.
    Peng C, Liu X, Liu E, Xu K, Niu W, Chen R, Wang J, Zhang Z, Lin P, Wang J, Agrez M, Niu J.
    Cancer Sci; 2009 Dec 19; 100(12):2302-8. PubMed ID: 19744110
    [Abstract] [Full Text] [Related]

  • 7. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.
    An WW, Gong XF, Wang MW, Tashiro S, Onodera S, Ikejima T.
    Acta Pharmacol Sin; 2004 Nov 19; 25(11):1502-8. PubMed ID: 15525474
    [Abstract] [Full Text] [Related]

  • 8. Norcantharidin-induced apoptosis is via the extracellular signal-regulated kinase and c-Jun-NH2-terminal kinase signaling pathways in human hepatoma HepG2 cells.
    Chen YN, Cheng CC, Chen JC, Tsauer W, Hsu SL.
    Br J Pharmacol; 2003 Oct 19; 140(3):461-70. PubMed ID: 12970086
    [Abstract] [Full Text] [Related]

  • 9. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling.
    Zhang S, Yang Y, Hua Y, Hu C, Zhong Y.
    Mol Med Rep; 2020 Aug 19; 22(2):774-782. PubMed ID: 32468032
    [Abstract] [Full Text] [Related]

  • 10. Repression of YAP by NCTD disrupts NSCLC progression.
    Guo J, Wu Y, Yang L, Du J, Gong K, Chen W, Dai J, Li X, Xi S.
    Oncotarget; 2017 Jan 10; 8(2):2307-2319. PubMed ID: 27903989
    [Abstract] [Full Text] [Related]

  • 11. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, Lu XS, Fan YZ.
    BMC Cancer; 2014 Mar 15; 14():193. PubMed ID: 24628713
    [Abstract] [Full Text] [Related]

  • 12. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
    Chen YJ, Kuo CD, Tsai YM, Yu CC, Wang GS, Liao HF.
    Anticancer Drugs; 2008 Jan 15; 19(1):55-64. PubMed ID: 18043130
    [Abstract] [Full Text] [Related]

  • 13. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.
    Liao HF, Su SL, Chen YJ, Chou CH, Kuo CD.
    Food Chem Toxicol; 2007 Sep 15; 45(9):1678-87. PubMed ID: 17442474
    [Abstract] [Full Text] [Related]

  • 14. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
    Xie D, Xie J, Wan Y, Ma L, Qi X, Wang K, Yang S.
    Oncol Rep; 2016 Apr 15; 35(4):2191-7. PubMed ID: 26781164
    [Abstract] [Full Text] [Related]

  • 15. Norcantharidin Enhances High Concentrations of Fetal Bovine Serum-Induced Apoptosis in Human Mesangial Cells by Regulating the Mitogen-Activated Protein Kinase Signaling Pathway.
    Ye K, Wei QY, Long TX, He HG, Huang YF, Xiong LJ, Lan J, Huang YY, Gong ZF, Peng XM, Wu QX.
    Kidney Blood Press Res; 2019 Apr 15; 44(6):1339-1351. PubMed ID: 31661692
    [Abstract] [Full Text] [Related]

  • 16. Norcantharidin Suppresses YD-15 Cell Invasion Through Inhibition of FAK/Paxillin and F-Actin Reorganization.
    Hong KO, Ahn CH, Yang IH, Han JM, Shin JA, Cho SD, Hong SD.
    Molecules; 2019 May 19; 24(10):. PubMed ID: 31109130
    [Abstract] [Full Text] [Related]

  • 17. Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.
    Liao HF, Chen YJ, Chou CH, Wang FW, Kuo CD.
    Toxicol In Vitro; 2011 Feb 19; 25(1):206-12. PubMed ID: 21075198
    [Abstract] [Full Text] [Related]

  • 18. Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer.
    He Q, Xue S, Tan Y, Zhang L, Shao Q, Xing L, Li Y, Xiang T, Luo X, Ren G.
    Cancer Lett; 2019 Apr 28; 448():94-104. PubMed ID: 30742942
    [Abstract] [Full Text] [Related]

  • 19. Norcantharidin combined with EGFR-TKIs overcomes HGF-induced resistance to EGFR-TKIs in EGFR mutant lung cancer cells via inhibition of Met/PI3k/Akt pathway.
    Wu H, Fan F, Liu Z, Shen C, Wang A, Lu Y.
    Cancer Chemother Pharmacol; 2015 Aug 28; 76(2):307-15. PubMed ID: 26063323
    [Abstract] [Full Text] [Related]

  • 20. Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio.
    Kok SH, Cheng SJ, Hong CY, Lee JJ, Lin SK, Kuo YS, Chiang CP, Kuo MY.
    Cancer Lett; 2005 Jan 10; 217(1):43-52. PubMed ID: 15596295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.